Skip to main content

Ajmer

 

Clinical courses

 

Clinical courses

  • State Health Committee invites applications from Pharmacists | 141 Openings

    Applications are invited from eligible candidates for post of Pharmacist in given districts under national health mission.

    Post: Pharmacist

  • Advertisement for Junior Research Fellow in CUR | M.Pharm

    Applications are invited for the post of Junior Research Fellow on purely temporary basis to work on the DST-sponsored research project to be undertaken at the Department of Pharmacy, Central University of Rajasthan.

    Post: Junior Research Fellow (JRF) - 01

  • MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

    { DOWNLOAD AS PDF }

    ABOUT AUTHORS:
    Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
    1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
    2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
    3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
    sureshrewar1990@gmail.com

    ABSTRACT
    A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.

  • MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS: AN EMERGING INFECTION

    ABOUT AUTHORS:
    Suresh Rewar1*, Dashrath Mirdha2, Prahlad Rewar3
    1Department of pharmaceutics, Rajasthan University of Health Sciences, Jaipur, Rajasthan,
    2Dr. Sarvepali Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, India
    3Jawaharlal Nehru Medical College, Ajmer, Rajasthan, India
    sureshrewar1990@gmail.com

    ABSTRACT
    A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East., A substantial number of Indians live and work in Gulf countries. People from India also travel to Saudi Arabia as Pilgrims to Hajj. The illness has a high mortality rate. Limited human-to-human transmission has occurred including transmission to health care workers. The source of the virus remains unclear, but camels are a possible source. Since April 2012 and as of 20 February 2015, 1042 cases (including 419 deaths) of Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported by local health authorities worldwide. Laboratory confirmation of MERS-CoV infections to date has largely been by real-time reverse transcription polymerase chain reaction (rRT-PCR) of lower respiratory tract specimens. Neither a vaccine nor effective therapy against the virus is available. Treatment consists of limited to supportive care, including mechanical ventilation for respiratory failure and/or hemodialysis in the setting of renal failure. Therapeutic modalities based on monoclonal antibodies (mAbs) have shown clinical success in the treatment of many diseases.

  • Vacancies for Pharmacists (168 posts) in RRB - Government of India

    Online applications are invited from eligible Indian Nationals for the following different Para-Medical Categories. Applications complete in all respects should be submitted only ONLINE to the concerned Railway Recruitment Board, as mentioned in Para-15 of General Instructions, till 23.59 Hrs of closing date.

    Post: Pharmacist - IIII

  • Work as Medical Representative in Viva Consultancy Services | 50 Vacancies

    Pharma company with OTC products sales having more than 8 years of market pretense across India

    Post: Medical Representative

  • Job in Maynor Recruitments for the post of Medical Representative | 10 Openings

    Headquartered in Mumbai, an India Limited company, a publicly listed company and a subsidiary which enjoys strong brand equity in multiple therapeutic categories such as Women's Health, Gastroenterology, Neurology, Thyroid, Diabetes & Urology Pain Management, Vitamins, Anti-Infectives & other therapy areas.
    Maynor recruitments

  • Walk in interview for Medical Representative in Ajanta Pharma

    Ajanta Pharma Limited is an emerging, global pharmaceutical company with proven capabilities in the areas of product research, manufacturing & marketing.

  • Walk in Interview for Pharmacy Faculty Posts in CUR

    The Central University of Rajasthan has been established by an Act of Parliament, the Central Universities Act 2009. The University started working temporarily from Jaipur and introduced two PG programmes in 2009-10, namely M.Sc./M.A. Statistics(Actuarial) and M.Sc.

  • Meyer Organics invites Medical Representatives, Area Manager, Regional Manager

    MEYER, an associate of U.K. based multinational VITABIOTICS LTD., is a rapidly growing Pharmaceutical company in India, with current turnover of 250 Crores, Ranking in Top 50 Indian Pharma Company.
    For our growth plan, we seek result oriented, self driven & focused Pharma Sales candidates as.

Subscribe to Ajmer